Showing 1 - 1 of 1 Stroke
MultiStem® Administration for Stroke Treatment and Enhanced Recovery Study (MASTERS-2)

Status: Enrolling

Investigator: David Chiu

Study Coordinator:

Phone:

A Phase 3 study to examine the safety and effectiveness of the allogeneic, adult stem cell investigational product, MultiStem, in adults who have suffered an acute ischemic stroke in the previous 18-36 hours. ... Read more >